Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XTLB Xtl生物制药

交易中 12-15 10:37:46 EST

0.8010

-0.0490

-5.76%

最高0.8601	最低0.8010	成交量7,444
今开0.8415	昨收0.8500	日振幅6.95%
总市值705.99万	流通市值361.96万	总股本881.39万
成交额6,249	换手率0.16%	流通股本451.89万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":0.801,"timestamp":1765812720450,"preClose":0.85,"halted":0,"volume":7444,"delay":0,"floatShares":4518888,"shares":8813851,"eps":-0.2999,"marketStatus":"交易中","change":-0.049,"latestTime":"12-15 10:37:46 EST","open":0.8415,"high":0.8601,"low":0.801,"amount":6248.5836724,"amplitude":0.069529,"askPrice":0.8601,"askSize":100,"bidPrice":0.7956,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.2999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":100,"exchange":"NASDAQ","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.8601,"preClose":0.85,"latestTime":"08:31 EST","volume":22,"amount":18.9222,"timestamp":1765805466485},"postHourTrading":{"tag":"盘后","latestPrice":0.85,"preClose":0.85,"latestTime":"16:00 EST","volume":1,"amount":0.85,"timestamp":1765573234218},"volumeRatio":1.720098},"requestUrl":"/m/hq/s/XTLB","defaultTab":"news","newsList":[{"id":"2588774147","title":"Xtl生物制药盘中异动 急速上涨10.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774147?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:30","pubTimestamp":1764599437,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时30分，Xtl生物制药股票出现波动，股价快速上涨10.40%。截至发稿，该股报0.920美元/股，成交量2.7113万股，换手率0.31%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。hCDR1是一种合成肽，包含大约20个氨基酸残基。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230379789e658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230379789e658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2586239288","title":"Xtl生物制药盘中异动 临近收盘股价大跌7.09%报0.775美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586239288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586239288?lang=zh_cn&edition=full","pubTime":"2025-11-26 04:46","pubTimestamp":1764103619,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日04时46分，Xtl生物制药股票出现异动，股价大幅跳水7.09%。截至发稿，该股报0.775美元/股，成交量2.487万股，换手率0.28%，振幅6.47%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.81%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126044700951a2c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126044700951a2c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2586117074","title":"Xtl生物制药盘中异动 早盘快速拉升5.13%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586117074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586117074?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:31","pubTimestamp":1763994681,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时31分，Xtl生物制药股票出现波动，股价快速上涨5.13%。截至发稿，该股报0.810美元/股，成交量2864股，换手率0.03%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.35%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223121a70e89f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223121a70e89f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2585716754","title":"Xtl生物制药盘中异动 临近收盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585716754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585716754?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:37","pubTimestamp":1763671048,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时37分，Xtl生物制药股票出现波动，股价快速下跌5.33%。截至发稿，该股报0.815美元/股，成交量1.5991万股，换手率0.18%，振幅8.36%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.50%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112104372897762cd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112104372897762cd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2575135427","title":"Xtl生物制药盘中异动 早盘股价大涨6.87%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575135427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575135427?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:32","pubTimestamp":1760535159,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时32分，Xtl生物制药股票出现波动，股价急速拉升6.87%。截至发稿，该股报1.40美元/股，成交量5.2603万股，换手率0.60%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.26%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521323994caf58e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521323994caf58e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2567677124","title":"Xtl生物制药盘中异动 急速下挫7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567677124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567677124?lang=zh_cn&edition=full","pubTime":"2025-09-16 00:07","pubTimestamp":1757952444,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日00时07分，Xtl生物制药股票出现波动，股价快速下挫7.37%。截至发稿，该股报1.25美元/股，成交量1935股，换手率0.02%，振幅7.41%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.13%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916000725a4c7c31c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916000725a4c7c31c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2558753667","title":"Xtl生物制药盘中异动 股价大涨8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558753667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558753667?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:27","pubTimestamp":1754940459,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时27分，Xtl生物制药股票出现异动，股价急速拉升8.09%。截至发稿，该股报1.47美元/股，成交量2520股，换手率0.03%，振幅5.88%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.44%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032739a6e016da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032739a6e016da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2557303063","title":"Xtl生物制药盘中异动 早盘快速上涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303063?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:42","pubTimestamp":1754491323,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时42分，Xtl生物制药股票出现异动，股价大幅拉升6.54%。截至发稿，该股报1.54美元/股，成交量1.1687万股，换手率0.13%，振幅9.32%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.10%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224203a478f61f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224203a478f61f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2555676839","title":"Xtl生物制药盘中异动 早盘股价大跌7.01%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555676839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555676839?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:33","pubTimestamp":1753968792,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时33分，Xtl生物制药股票出现波动，股价急速下跌7.01%。截至发稿，该股报1.53美元/股，成交量1613股，换手率0.02%，振幅2.44%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.76%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213312a6cbcaae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213312a6cbcaae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2555050683","title":"Xtl生物制药盘中异动 早盘股价大涨6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555050683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555050683?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:13","pubTimestamp":1753802006,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时13分，Xtl生物制药股票出现波动，股价急速拉升6.59%。截至发稿，该股报1.78美元/股，成交量4438股，换手率0.05%，振幅8.08%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.34%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072923132794c1ce0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072923132794c1ce0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2554377223","title":"Xtl生物制药盘中异动 早盘急速跳水6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554377223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554377223?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:40","pubTimestamp":1753710000,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时40分，Xtl生物制药股票出现异动，股价大幅跳水6.29%。截至发稿，该股报1.64美元/股，成交量3075股，换手率0.03%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.22%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214000a6c61909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214000a6c61909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2552482666","title":"Xtl生物制药盘中异动 股价大涨5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482666?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:37","pubTimestamp":1752759448,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时37分，Xtl生物制药股票出现异动，股价大幅拉升5.30%。截至发稿，该股报1.59美元/股，成交量38股，换手率0.00%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.30%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071721372897a9d5c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071721372897a9d5c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2551180335","title":"Xtl生物制药盘中异动 急速下跌11.92%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551180335?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:31","pubTimestamp":1752499916,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时31分，Xtl生物制药股票出现波动，股价快速下挫11.92%。截至发稿，该股报1.33美元/股，成交量1.0764万股，换手率0.12%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.17%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213156a44a1d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213156a44a1d47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2550811939","title":"Xtl生物制药7月10日成交额为1.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550811939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550811939?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:31","pubTimestamp":1752222713,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Xtl生物制药成交额为1.49万美元，成交额较昨日减少89.24%，当日成交量为9614.00股。Xtl生物制药于2025年7月10日跌5.0%，报1.52美元，该股过去5个交易日涨26.67%，年初至今跌25.12%，过去60日涨34.51%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽，包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173012a4448342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173012a4448342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2550624251","title":"Xtl生物制药盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550624251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550624251?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:30","pubTimestamp":1752161414,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时30分，Xtl生物制药股票出现异动，股价大幅跳水5.00%。截至发稿，该股报1.52美元/股，成交量5333股，换手率0.06%，振幅3.13%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.71%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023301497a1200c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023301497a1200c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2550193648","title":"Xtl生物制药7月9日成交额为13.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550193648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550193648?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:24","pubTimestamp":1752135878,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Xtl生物制药成交额为13.88万美元，成交额较昨日增加801.92%，当日成交量为9.33万股。Xtl生物制药于2025年7月9日涨30.08%，报1.6美元，该股过去5个交易日涨35.59%，年初至今跌21.18%，过去60日涨37.93%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽，包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171212a6a14323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171212a6a14323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2550992682","title":"Xtl生物制药7月8日成交额为1.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550992682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550992682?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:13","pubTimestamp":1752048835,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Xtl生物制药成交额为1.54万美元，成交额较昨日减少16.16%，当日成交量为1.22万股。Xtl生物制药于2025年7月8日涨0.82%，报1.23美元，该股过去5个交易日涨7.89%，年初至今跌39.41%，过去60日涨5.13%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽，包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709164735a69f013c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709164735a69f013c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2549517005","title":"Xtl生物制药盘中异动 下午盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549517005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549517005?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:25","pubTimestamp":1751909155,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日01时25分，Xtl生物制药股票出现异动，股价急速上涨5.30%。截至发稿，该股报1.39美元/股，成交量5672股，换手率0.06%，振幅5.52%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.61%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012555979d4765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012555979d4765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2548394377","title":"Xtl生物制药7月3日成交额为5.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548394377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548394377?lang=zh_cn&edition=full","pubTime":"2025-07-04 15:46","pubTimestamp":1751615172,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Xtl生物制药成交额为5.64万美元，成交额较昨日增加40.92%，当日成交量为4.38万股。Xtl生物制药于2025年7月3日涨10.0%，报1.32美元，该股过去5个交易日涨11.86%，年初至今跌34.98%，过去60日涨16.81%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽，包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704160524a72e570a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704160524a72e570a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2548781469","title":"Xtl生物制药盘中异动 下午盘快速上涨7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548781469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548781469?lang=zh_cn&edition=full","pubTime":"2025-07-03 01:40","pubTimestamp":1751478050,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日01时40分，Xtl生物制药股票出现异动，股价急速上涨7.23%。截至发稿，该股报1.26美元/股，成交量2469股，换手率0.03%，振幅5.11%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.99%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301405097978d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301405097978d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1237},{"period":"3month","weight":-0.3701},{"period":"6month","weight":-0.2411},{"period":"1year","weight":-0.5304},{"period":"ytd","weight":-0.5804}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发，为了满足未得到满足的医疗需求。最近在致力于MM的治疗，精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.099791},{"month":2,"riseRate":0.375,"avgChangeRate":-0.035412},{"month":3,"riseRate":0.375,"avgChangeRate":0.154077},{"month":4,"riseRate":0.4375,"avgChangeRate":-0.01928},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.059048},{"month":6,"riseRate":0.466667,"avgChangeRate":0.000234},{"month":7,"riseRate":0.4375,"avgChangeRate":0.469627},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.037628},{"month":9,"riseRate":0.1875,"avgChangeRate":-0.076581},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.025328},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.062792},{"month":12,"riseRate":0.294118,"avgChangeRate":-0.045923}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}